LYST THERAPEUTICS
Lyst Therapeutics is a project at Nationwide Children's Research Institute to determine the effect of LYST antibody on inhibiting the formation of tissue engineered vascular graft stenosis.
LYST THERAPEUTICS
Industry:
Health Care Hospital Therapeutics
Founded:
2015-01-01
Address:
Columbus, Ohio, United States
Country:
United States
Website Url:
http://www.lysttherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
400 K USD
Technology used in webpage:
Google Font API Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare JS CDN JS
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
SonoSolve
A revolutionary new device that aims to eliminate catheter-associated complications
Current Advisors List
Current Employees Featured
Founder
Investors List
Rev1 Ventures
Rev1 Ventures investment in Seed Round - Lyst Therapeutics
Official Site Inspections
http://www.lysttherapeutics.com
Unable to get host informations!!!
More informations about "Lyst Therapeutics"
Lyst Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Lyst Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Lyst Therapeutics - Crunchbase Company Profile & Funding
Lyst Therapeutics is a project at Nationwide Children's Research Institute to determine the effect of LYST antibody on inhibiting the formation of tissue engineered vascular graft stenosis. …See details»
LYST Therapeutics Company Profile | Management and Employees …
Lyst Therapeutics is an early stage biopharmaceutical startup focusing on a novel immunomodulatory target, the lysosomal trafficking regulator ("LYST") protein.See details»
Lyst Therapeutics LLC: Drug pipelines, Patents, Clinical trials
Jul 7, 2023 · Explore Lyst Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, .See details»
Lyst Therapeutics LLC - VentureRadar
Find out more about Lyst Therapeutics LLC including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Lyst Therapeutics - Company Profile - Tracxn
Jul 11, 2024 · Lyst Therapeutics - Provider of therapeutics solution for congenital heart diseases targeting the immunomodulator. Raised funding from 1 investor. Founded by Cameron Best …See details»
Lyst Therapeutics - Company Profile - Tracxn
Oct 30, 2024 · Developer of monoclonal antibody therapies to treat cardiovascular fibrosis. The company is focusing on a novel immunomodulatory target, the lysosomal trafficking regulator …See details»
BIO Member Directory
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
NIH 2020 Development of a Lystamab Coated Pericardial …
Www.lysttherapeutics.com: Location: Single Congr. District: 15 County: Franklin. Phase I Contract Number: 1R43HL152844-01 Start Date: 9/22/2020 Completed: 8/31/2021. Phase I year 2020. …See details»
Development of a LystaMab coated pericardial adhesion barrier
Email: [email protected]. Business Contact. Name: MARGARET GROH Phone: (216) 374-4502 Email: [email protected]. Research Institution. N/A . Abstract. SUMMARY …See details»
Lyst Therapeutics LLC: 药物管线，专利，临床试验 - 智慧芽新药情 …
了解Lyst Therapeutics LLC公司的药物管线，治疗领域，技术平台，以及它的。See details»
Named Research Organizations - Minister for Science
To ensure compliance with the Policy on Sensitive Technology Research and Affiliations of Concern, all researchers involved in activities funded by a research grant that advance a …See details»
sprayman.co Reviews: Is this site a scam or legit?
Is sprayman.co legit? It's definitely questionable. If you plan to do business on this site, proceed with caution as it received a medium score on our chart. We put to work 53 powerful factors to …See details»
ORCID
ORCID is a free, unique, persistent identifier (PID) for individuals to use as they engage in research, scholarship, and innovation activities. Learn how ORCID can help you spend more …See details»
Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ...
BASKING RIDGE, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (or the “Company”), a clinical-stage pharmaceutical company developing …See details»
Targeting lysine acetylation readers and writers - Nature
Nov 21, 2024 · Lysine acetylation is a major post-translational modification in histones and other proteins that is catalysed by the ‘writer’ lysine acetyltransferases (KATs) and mediates …See details»
Homepage - The Church of Jesus Christ of Latter-day Saints
Learn more about Sunday services or find a church near you. Why does The Church of Jesus Christ of Latter-day Saints have temples? For Latter-day Saints, a temple is different from …See details»
My Account
Access and manage your Microsoft account and organizations.See details»
10 Principles of Effective Organizations - Harvard Business Review
Aug 8, 2022 · The author identifies 10 research-backed principles from the field of organization development to guide companies: 1) Encourage cooperation, 2) organize for change, 3) …See details»
About Yoga Alliance - More Yoga, Better World
We are the largest nonprofit member association representing the global yoga community, and we believe that if more people practice yoga, the better the world will be. We are here to set the …See details»